Xianxiao Zhou

Xianxiao Zhou

Auto-generated profile, based on publicly available information

Xianxiao Zhou

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Nature
Verified
Journal Article
Closed access
PDF file
JHJi-Yeun Hur
Ji-Yeun Hur
GFGeorgia R. Frost
Georgia R. Frost
XWXianzhong Wu
Xianzhong Wu
CCChristina Crump
Christina Crump
SPSi Jia Pan
Si Jia Pan
YLYue-Ming Li
Yue-Ming Li

19 August 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ZLZachary S. Lorsch
Zachary S. Lorsch
PHPeter J Hamilton
Peter J Hamilton
ARAarthi Ramakrishnan
Aarthi Ramakrishnan
EPEric M. Parise
Eric M. Parise
MSMarine Salery
Marine Salery
ENEric J Nestler
Eric J Nestler

20 November 2019 in Nature Communications
Verified
Journal Article
Open access
QWQian Wang
Qian Wang
YZYuanxi Zhang
Yuanxi Zhang
MWMinghui Wang
Minghui Wang
WSWon-Min Song
Won-Min Song
QSQi Shen
Qi Shen
BZBin Zhang
Bin Zhang
Genetic and genomic studies have advanced our knowledge of inherited Parkinson’s disease (PD), however, the etiology and pathophysiology of idiopathic PD remain unclear. Herein, we perform a meta-analysis of 8 PD postmortem brain transcriptome studies by employing a multiscale network biology approach to delineate the gene-gene regulatory structures in the substantia nigra and determine key regulators of the PD transcriptomic networks. We identify STMN2, which encodes a stathmin family protein and is down-regulated in PD brains, as a key regulator functionally connected to known PD risk genes. Our network analysis predicts a function of human STMN2 in synaptic trafficking, which is validated in Stmn2-knockdown mouse dopaminergic neurons. Stmn2 reduction in the mouse midbrain causes dopaminergic neuron degeneration, phosphorylated α-synuclein elevation, and locomotor deficits. Our integrative analysis not only begins to elucidate the global landscape of PD transcriptomic networks but also pinpoints potential key regulators of PD pathogenic pathways.

10 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MLMandy M. T. van Leent
Mandy M. T. van Leent
TBThijs J. Beldman
Thijs J. Beldman
YTYohana C. Toner
Yohana C. Toner
MLMarnix A. Lameijer
Marnix A. Lameijer
NRNils Rother
Nils Rother
RDRaphaël Duivenvoorden
Raphaël Duivenvoorden
Macrophages play a central role in the pathogenesis of atherosclerosis. The inflammatory properties of these cells are dictated by their metabolism, of which the mechanistic target of rapamycin (mTOR) signaling pathway is a key regulator. Using myeloid cell–specific nanobiologics in apolipoprotein E–deficient (Apoe−/−) mice, we found that targeting the mTOR and ribosomal protein S6 kinase-1 (S6K1) signaling pathways rapidly diminished plaque macrophages’ inflammatory activity. By investigating transcriptome modifications, we identified Psap, a gene encoding the lysosomal protein prosaposin, as closely related with mTOR signaling. Subsequent in vitro experiments revealed that Psap inhibition suppressed both glycolysis and oxidative phosphorylation. Transplantation of Psap−/− bone marrow to low-density lipoprotein receptor knockout (Ldlr−/−) mice led to a reduction in atherosclerosis development and plaque inflammation. Last, we confirmed the relationship between PSAP expression and inflammation in human carotid atherosclerotic plaques. Our findings provide mechanistic insights into the development of atherosclerosis and identify prosaposin as a potential therapeutic target.

26 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
SWShalaka Wahane
Shalaka Wahane
XZXianxiao Zhou
Xianxiao Zhou
XZXiang Zhou
Xiang Zhou
LGLei Guo
Lei Guo
MFMarie-Sophie Friedl
Marie-Sophie Friedl
HZHongyan Zou
Hongyan Zou
Transcriptional maps reveal diverse responses of immune and glial cells in spinal cord injury.

22 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
WSWon-Min Song
Won-Min Song
PAPraveen Agrawal
Praveen Agrawal
RIRichard Von Itter
Richard Von Itter
BFBarbara Fontanals-Cirera
Barbara Fontanals-Cirera
MWMinghui Wang
Minghui Wang
BZBin Zhang
Bin Zhang
Melanoma is the most lethal skin malignancy, driven by genetic and epigenetic alterations in the complex tumour microenvironment. While large-scale molecular profiling of melanoma has identified molecular signatures associated with melanoma progression, comprehensive systems-level modeling remains elusive. This study builds up predictive gene network models of molecular alterations in primary melanoma by integrating large-scale bulk-based multi-omic and single-cell transcriptomic data. Incorporating clinical, epigenetic, and proteomic data into these networks reveals key subnetworks, cell types, and regulators underlying melanoma progression. Tumors with high immune infiltrates are found to be associated with good prognosis, presumably due to induced CD8+ T-cell cytotoxicity, via MYO1F-mediated M1-polarization of macrophages. Seventeen key drivers of the gene subnetworks associated with poor prognosis, including the transcription factor ZNF180, are tested for their pro-tumorigenic effects in vitro. The anti-tumor effect of silencing ZNF180 is further validated using in vivo xenografts. Experimentally validated targets of ZNF180 are enriched in the ZNF180 centered network and the known pathways such as melanoma cell maintenance and immune cell infiltration. The transcriptional networks and their critical regulators provide insights into the molecular mechanisms of melanomagenesis and pave the way for developing therapeutic strategies for melanoma.